FDA Approves ForeseeHome AMD Monitor from Notal Vision

February 10, 2010

Notal Vision recently announced that its ForeseeHome™ AMD Monitor has received Section 510 (k) clearance from the FDA.

The ForeseeHome AMD Monitor is the first ophthalmic device linking patients and doctors between eye exams for ongoing monitoring of age-related macular degeneration (AMD).  Patients complete a frequent but brief exam on their ForeseeHome AMD Monitor, in the comfort of their own home, and data is transmitted to the patients’ eye care physician and the Notal Vision Data Monitoring Center.  The award winning ergonomic design of the ForeseeHome AMD Monitor is comfortable and easy to use for patients at risk of vision loss from wet AMD.

Read the full release.




Jump down to form below to submit your own comments

Comments are closed.